Evidence map›Paper›PMID 40075463›Full record

ArticleActa neuropathologica communications2025

Collision tumor, a metastatic melanoma within a meningioma: a case report.

Erika Yamazawa, Daniel P Cahill, Matthew P Frosch, Priscilla K Brastianos, Ryan J Sullivan

Abstract readCase Reports
In one paragraph

Article in Acta neuropathologica communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erika YamazawaCenter for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Daniel P CahillDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Matthew P FroschDepartment of Pathology, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA.
Priscilla K Brastianos *Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA. pbrastianos@mgh.harvard.edu.
Ryan J Sullivan *Massachusetts General Hospital, Mass General Cancer Center, Harvard Medical School, Boston, Massachusetts, USA. rsullivan7@mgh.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCollision tumors, involving two distinct neoplasms in a single anatomical site, are rare. Among these, the metastasis of melanoma into an intracranial meningioma is particularly uncommon, with only four previously reported cases. Melanoma, known for its aggressive metastatic potential, contrasts sharply with the small number of collision tumor reports. The coexistence of these tumors poses diagnostic and therapeutic challenges, particularly in patients with a stable meningiomas.

resultsWe present the fifth documented case of melanoma metastasizing to a meningioma, the first to include genetic analysis revealing an NRAS mutation in the melanoma. The patient, a 58-year-old man, developed a hemorrhagic transformation of a stable left frontal meningioma. Surgical resection confirmed a biphasic tumor with melanoma cells infiltrating the meningioma. Despite initial treatment with immune checkpoint inhibitors, the patient's condition progressed with widespread metastatic melanoma, ultimately leading to death.

conclusionsThe rarity of reported melanoma-to-meningioma metastasis highlights the need for further research into the genetic and pathophysiological mechanisms underlying tumor-to-tumor metastasis. Advances in genomic technologies could help identify biomarkers associated with such rare phenomena. This case also emphasizes the importance of monitoring patients with stable meningiomas and a history of melanoma for potential metastasis. Future research should explore whether prophylactic management of benign meningiomas could mitigate this risk and assess the long-term outcomes of collision tumors compared to typical metastatic brain tumors.

Indexed as

MelanomaMeningeal NeoplasmsMeningiomaNeoplasms, Multiple PrimaryFatal OutcomeGTP PhosphohydrolasesHumansMaleMembrane ProteinsMiddle AgedGTP PhosphohydrolasesMembrane ProteinsNRAS protein, humanCollision tumorMelanomaMeningiomaTumor-to-tumor metastasis (TTM)

Identifiers

PMID40075463
PMCPMC11900604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.